Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial

Caused by viral infection, postherpetic neuralgia (PHN) is the most common chronic neuropathic pain. Various treatment modalities such as early use of nerve block therapy (NBT) and pulsed radiofrequency (PRF) have been studied in reducing pain, however, no consistent success was achieved in all the...

Full description

Bibliographic Details
Main Authors: Dan Li, Guohua Sun, Hanzhe Sun, Yanjuan Wang, Zhiping Wang, Jianping Yang
Format: Article
Language:English
Published: PeerJ Inc. 2018-06-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/4852.pdf
_version_ 1797425524794982400
author Dan Li
Guohua Sun
Hanzhe Sun
Yanjuan Wang
Zhiping Wang
Jianping Yang
author_facet Dan Li
Guohua Sun
Hanzhe Sun
Yanjuan Wang
Zhiping Wang
Jianping Yang
author_sort Dan Li
collection DOAJ
description Caused by viral infection, postherpetic neuralgia (PHN) is the most common chronic neuropathic pain. Various treatment modalities such as early use of nerve block therapy (NBT) and pulsed radiofrequency (PRF) have been studied in reducing pain, however, no consistent success was achieved in all the patients treated with single regimen. The combined therapy of PRF and NBT with different targeting mechanism are of interest and remains to be determined. Here we investigated the combined effects of pulsed radiofrequency (PRF) with nerve block therapy (NBT) in PHN patients in a prospective randomized clinical trial. Sixty PHN patients were divided into four groups (n = 15 each): the conventional puncture group (group CP), the nerve block therapy group (group NB), the PRF group (group PRF), and the combined treatment group (PRF combined with nerve block therapy (group CT). To evaluate the extent of remission of hyperalgesia, we recorded the visual analogue scale (VAS) scores during cotton swab reaction before and after treatment and in the resting and active pain states. In addition, blood samples were collected and plasma cytokine and neuropeptides such as interleukin-6 (IL-6), substance P (SP), and β-endorphin (β-EP) were measured by enzyme-linked immunosorbent assay (ELISA) at the admission (basic state), before the operation, and at 12 h postoperatively. The number of adverse events (nausea, vomiting, constipation, puncture point hemorrhage, swelling and redness) within 12 h of the treatment were also documented. Our results showed that VAS scores during cotton swab reaction decreased after treatment in all patients (p < 0.05). Compared to group CP, plasma IL-6 and SP levels decreased (p < 0.05) and β-EP levels increased (p < 0.05) in groups NB, PRF, and CT. There were no significant differences in adverse events among groups (p > 0.05). We found that PRF in combination with NBT increased β-EP levels and decreased plasma IL-6 and SP, thereby alleviating pain and hyperalgesia in PHN patients. Taken together, our data suggest combined therapy of PRF and NBT is effective and safe for PHN patients.
first_indexed 2024-03-09T08:17:22Z
format Article
id doaj.art-2137f0dd99764310a3b91affe4aeada2
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T08:17:22Z
publishDate 2018-06-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-2137f0dd99764310a3b91affe4aeada22023-12-02T22:00:55ZengPeerJ Inc.PeerJ2167-83592018-06-016e485210.7717/peerj.4852Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trialDan Li0Guohua Sun1Hanzhe Sun2Yanjuan Wang3Zhiping Wang4Jianping Yang5Department of Anesthesiology, Wuxi People’s Hospital, Wuxi, ChinaDepartment of Anesthesiology, Wuxi People’s Hospital, Wuxi, ChinaDepartment of Anesthesiology, Wuxi People’s Hospital, Wuxi, ChinaDepartment of Anesthesiology, Wuxi People’s Hospital, Wuxi, ChinaDepartment of Anesthesiology, Wuxi People’s Hospital, Wuxi, ChinaDepartment of Anesthesiology, The First Hospital Affiliated to Soochow University, Suzhou, ChinaCaused by viral infection, postherpetic neuralgia (PHN) is the most common chronic neuropathic pain. Various treatment modalities such as early use of nerve block therapy (NBT) and pulsed radiofrequency (PRF) have been studied in reducing pain, however, no consistent success was achieved in all the patients treated with single regimen. The combined therapy of PRF and NBT with different targeting mechanism are of interest and remains to be determined. Here we investigated the combined effects of pulsed radiofrequency (PRF) with nerve block therapy (NBT) in PHN patients in a prospective randomized clinical trial. Sixty PHN patients were divided into four groups (n = 15 each): the conventional puncture group (group CP), the nerve block therapy group (group NB), the PRF group (group PRF), and the combined treatment group (PRF combined with nerve block therapy (group CT). To evaluate the extent of remission of hyperalgesia, we recorded the visual analogue scale (VAS) scores during cotton swab reaction before and after treatment and in the resting and active pain states. In addition, blood samples were collected and plasma cytokine and neuropeptides such as interleukin-6 (IL-6), substance P (SP), and β-endorphin (β-EP) were measured by enzyme-linked immunosorbent assay (ELISA) at the admission (basic state), before the operation, and at 12 h postoperatively. The number of adverse events (nausea, vomiting, constipation, puncture point hemorrhage, swelling and redness) within 12 h of the treatment were also documented. Our results showed that VAS scores during cotton swab reaction decreased after treatment in all patients (p < 0.05). Compared to group CP, plasma IL-6 and SP levels decreased (p < 0.05) and β-EP levels increased (p < 0.05) in groups NB, PRF, and CT. There were no significant differences in adverse events among groups (p > 0.05). We found that PRF in combination with NBT increased β-EP levels and decreased plasma IL-6 and SP, thereby alleviating pain and hyperalgesia in PHN patients. Taken together, our data suggest combined therapy of PRF and NBT is effective and safe for PHN patients.https://peerj.com/articles/4852.pdfNerve block therapyPulsed radiofrequencyPostherpetic neuralgia
spellingShingle Dan Li
Guohua Sun
Hanzhe Sun
Yanjuan Wang
Zhiping Wang
Jianping Yang
Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial
PeerJ
Nerve block therapy
Pulsed radiofrequency
Postherpetic neuralgia
title Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial
title_full Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial
title_fullStr Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial
title_full_unstemmed Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial
title_short Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial
title_sort combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients a randomized clinical trial
topic Nerve block therapy
Pulsed radiofrequency
Postherpetic neuralgia
url https://peerj.com/articles/4852.pdf
work_keys_str_mv AT danli combinedtherapyofpulsedradiofrequencyandnerveblockinpostherpeticneuralgiapatientsarandomizedclinicaltrial
AT guohuasun combinedtherapyofpulsedradiofrequencyandnerveblockinpostherpeticneuralgiapatientsarandomizedclinicaltrial
AT hanzhesun combinedtherapyofpulsedradiofrequencyandnerveblockinpostherpeticneuralgiapatientsarandomizedclinicaltrial
AT yanjuanwang combinedtherapyofpulsedradiofrequencyandnerveblockinpostherpeticneuralgiapatientsarandomizedclinicaltrial
AT zhipingwang combinedtherapyofpulsedradiofrequencyandnerveblockinpostherpeticneuralgiapatientsarandomizedclinicaltrial
AT jianpingyang combinedtherapyofpulsedradiofrequencyandnerveblockinpostherpeticneuralgiapatientsarandomizedclinicaltrial